Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Genemind Biosciences Co. Ltd. has 7 pending office actions focused in the Biotechnology & Pharmaceuticals technology area. The prosecution of these matters involves 7 distinct examiners, meaning each examiner is currently handling exactly one action for the company. This one-to-one ratio between actions and examiners suggests a lack of examiner-level consolidation in the company's current portfolio.
These 7 pending actions are spread across 4 distinct art units. HERNANDEZ, JACKSON J is the busiest examiner assigned to the portfolio, currently overseeing 1 pending office action. This distribution suggests that the company interacts with a variety of specialized units within its primary technology sector. Because there are 7 distinct examiners but only 4 distinct art units, some of these examiners are working within the same art unit. This requires the company to manage multiple individual relationships even when dealing with the same technical group at the patent office.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HERNANDEZ, JACKSON J | 1 | 51.4% | +45.0% |
| WHALEY, PABLO S | 1 | 25.1% | +21.4% |
| GARBER, ERIN R | 1 | 82.7% | +17.7% |
| MILIA, MARK R | 1 | 58.9% | +22.2% |
| CROCKETT, RYAN M | 1 | 78.8% | +5.4% |
| MERLIN, JESSICA M | 1 | 61.7% | +24.0% |
| CROW, ROBERT THOMAS | 1 | 41.7% | +32.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | CROW, ROBERT THOMAS | 29d |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | WHALEY, PABLO S | — |
| 18961674 | OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM | GARBER, ERIN R | — |
| 18818954 | IMAGING SYSTEM, SEQUENCING SYSTEM, AND IMAGING METHOD | CROCKETT, RYAN M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | HERNANDEZ, JACKSON J | 30d overdue |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | CROW, ROBERT THOMAS | 29d |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | WHALEY, PABLO S | — |
| 18961674 | OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM | GARBER, ERIN R | — |
| 18950631 | METHOD AND APPARATUS FOR DETERMINING INTER-CHANNEL CROSSTALK CORRECTION STRENGTH, AND MEDIUM | MILIA, MARK R | — |
| 18798368 | IMAGING SYSTEM AND SEQUENCING SYSTEM | MERLIN, JESSICA M | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 3619 | 1 |
| 2878 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18880793 | SURFACE TREATMENT METHOD, SEQUENCING METHOD, AND KIT | HERNANDEZ, JACKSON J | 1627 | §112 | Final Rejection | 30d overdue | Pending | Jan 02, 2025 |
| 18999061 | METHOD AND APPARATUS FOR DETECTING CHROMOSOMAL ANEUPLOIDY, DEVICE AND STORAGE MEDIUM | WHALEY, PABLO S | 3619 | §101§102§112 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18961674 | OPTOMECHANICAL SYSTEM AND SEQUENCING SYSTEM | GARBER, ERIN R | 2878 | §103§112 | Non-Final OA | — | Pending | Nov 27, 2024 |
| 18950631 | METHOD AND APPARATUS FOR DETERMINING INTER-CHANNEL CROSSTALK CORRECTION STRENGTH, AND MEDIUM | MILIA, MARK R | — | §103 | Non-Final OA | — | Pending | Nov 18, 2024 |
| 18818954 | IMAGING SYSTEM, SEQUENCING SYSTEM, AND IMAGING METHOD | CROCKETT, RYAN M | — | §102§103 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18798368 | IMAGING SYSTEM AND SEQUENCING SYSTEM | MERLIN, JESSICA M | — | §103 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18020915 | AMINO-MODIFIED CHIP, PREPARATION METHOD THEREFOR AND USE THEREOF | CROW, ROBERT THOMAS | 1682 | §103§112 | Non-Final OA | 29d | Pending | Feb 10, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial